UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective

Diabetes, obesity & metabolism, 2014-04, Vol.16 (4), p.366-375

2014

Volltextzugriff (PDF)

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources

Diabetic medicine, 2016-04, Vol.33 (4), p.471-477

2016

Volltextzugriff (PDF)

What is innovation in the area of medicines? The example of insulin and diabetes

Diabetic medicine, 2019-12, Vol.36 (12), p.1528-1529

2019

Volltextzugriff (PDF)

Development and validation of a cost-utility model for Type 1 diabetes mellitus

Diabetic medicine, 2015-08, Vol.32 (8), p.1023-1035

2015

Volltextzugriff (PDF)

Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's disease

Alzheimer's research & therapy, 2024-02, Vol.16 (1), p.48-11, Article 48

2024

Volltextzugriff (PDF)

Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data

Current medical research and opinion, 2017-04, Vol.33 (4), p.647-655

2017

Volltextzugriff (PDF)

Income-related inequality in utilization of health services in Denmark: Evidence from Funen County

Scandinavian journal of public health, 2006-10, Vol.34 (5), p.462-471

GUNDGAARD, JENS

2006

Volltextzugriff (PDF)

Income related inequality in prescription drugs in Denmark

Pharmacoepidemiology and drug safety, 2005-05, Vol.14 (5), p.307-317

Gundgaard, Jens

2005

Volltextzugriff (PDF)

Use of six main drug therapeutic groups across educational groups: self-reported survey and prescription records

Journal of clinical pharmacy and therapeutics, 2005-06, Vol.30 (3), p.259-269

2005

Volltextzugriff (PDF)

The effect of non-response on estimates of health care utilisation: linking health surveys and registers

European journal of public health, 2008-04, Vol.18 (2), p.189-194

2008

Volltextzugriff (PDF)

Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective

Patient preference and adherence, 2013-01, Vol.7 (default), p.925-936

2013

Volltextzugriff (PDF)

Increased intake of fruit and vegetables: estimation of impact in terms of life expectancy and healthcare costs

Public health nutrition, 2003-02, Vol.6 (1), p.25-30

2003

Volltextzugriff (PDF)

Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease

International journal of technology assessment in health care, 2005-04, Vol.21 (2), p.194-202

2005

Volltextzugriff (PDF)

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

Diabetes therapy, 2021-01, Vol.12 (1), p.373-388

2021

Volltextzugriff (PDF)

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK

Diabetes therapy, 2018-06, Vol.9 (3), p.1217-1232

2018

Volltextzugriff (PDF)

The Danish Testicular Cancer database

Clinical epidemiology, 2016-01, Vol.8, p.703-707

2016

Volltextzugriff (PDF)

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)

Applied health economics and health policy, 2019-10, Vol.17 (5), p.615-627

2019

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Zeitschrift / SerieJournal Of Medical Economics

Zeitschrift / SerieValue In Health

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(12)
Adult
(9)
Diabetes
(9)
Female
(8)
Male
(8)
Hypoglycemia
(7)
Insulin
(6)
Middle Aged
(6)
Public, Environmental & Occupational Health
(6)
Endocrinology & Metabolism
(5)
Patients
(5)
Cost Analysis
(4)
Cost-Benefit Analysis
(4)
Health Care Costs
(4)
Health Economics
(4)
Hypoglycemic Agents - Economics
(4)
Medical Research
(4)
Adolescent
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources

What is innovation in the area of medicines? The example of insulin and diabetes

Development and validation of a cost-utility model for Type 1 diabetes mellitus

Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's disease

Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data

Income-related inequality in utilization of health services in Denmark: Evidence from Funen County

Income related inequality in prescription drugs in Denmark

Use of six main drug therapeutic groups across educational groups: self-reported survey and prescription records

The effect of non-response on estimates of health care utilisation: linking health surveys and registers

Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective

Increased intake of fruit and vegetables: estimation of impact in terms of life expectancy and healthcare costs

Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK

The Danish Testicular Cancer database

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)

Aktive Filter

Suchergebnisse filtern